par Toller Erausquin, Jennifer;Tan, Rayner Kay Jin;Uhlich, Maximiliane;Francis, Joel J.M.;Kumar, Navin;Campbell, Linda;Zhang, Wei Hong ;Hlatshwako, Takhona Grace;Kosana, Priya;Shah, Sonam;Brenner, Erica E.M.;Remmerie, Lore;Mussa, Aamirah;Klapilova, Katerina;Mark, Kristen;Perotta, Gabriela;Gabster, Amanda;Wouters, Edwin;Burns, Sharyn;Hendriks, Jacqueline;Hensel, Devon D.J.;Shamu, Simukai;Marie Strizzi, Jenna;Esho, Tammary;Morroni, Chelsea;Eleuteri, Stefano;Sahril, Norhafiza;Yun Low, Wah;Plasilova, Leona;Lazdane, Gunta;Marks, Michael;Olumide, Adesola;Abdelhamed, Amr;López Gómez, Alejandra;Michielsen, Kristien;Moreau, Caroline;Tucker, Joseph J.D.
Référence Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 75, 1, page (e991-e999)
Publication Publié, 2022-08-01
Référence Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 75, 1, page (e991-e999)
Publication Publié, 2022-08-01
Article révisé par les pairs
Résumé : | BACKGROUND: There is limited evidence to date about changes to sexual and reproductive health (SRH) during the initial wave of coronavirus disease 2019 (COVID-19). To address this gap, our team organized a multicountry, cross-sectional online survey as part of a global consortium. METHODS: Consortium research teams conducted online surveys in 30 countries. Sampling methods included convenience, online panels, and population-representative. Primary outcomes included sexual behaviors, partner violence, and SRH service use, and we compared 3 months prior to and during policy measures to mitigate COVID-19. We conducted meta-analyses for primary outcomes and graded the certainty of the evidence. RESULTS: Among 4546 respondents with casual partners, condom use stayed the same for 3374 (74.4%), and 640 (14.1%) reported a decline. Fewer respondents reported physical or sexual partner violence during COVID-19 measures (1063 of 15 144, 7.0%) compared to before COVID-19 measures (1469 of 15 887, 9.3%). COVID-19 measures impeded access to condoms (933 of 10 790, 8.7%), contraceptives (610 of 8175, 7.5%), and human immunodeficiency virus/sexually transmitted infection (HIV/STI) testing (750 of 1965, 30.7%). Pooled estimates from meta-analysis indicate that during COVID-19 measures, 32.3% (95% confidence interval [CI], 23.9%-42.1%) of people needing HIV/STI testing had hindered access, 4.4% (95% CI, 3.4%-5.4%) experienced partner violence, and 5.8% (95% CI, 5.4%-8.2%) decreased casual partner condom use (moderate certainty of evidence for each outcome). Meta-analysis findings were robust in sensitivity analyses that examined country income level, sample size, and sampling strategy. CONCLUSIONS: Open science methods are feasible to organize research studies as part of emergency responses. The initial COVID-19 wave impacted SRH behaviors and access to services across diverse global settings. |